On Aug. 31, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals…
On Aug. 31, 2021, Novartis announced a commercial agreement with the NHS in England as part of a…
On Aug. 31, 2021, SK bioscience and GlaxoSmithKline announced the initiation of a Phase 3 clinical study of…
On Aug. 30, 2021, OPKO announced completion of enrollment in its Phase 2 trial with RAYALDEEﾮ as a…
On Aug. 30, 2021, CureVac announced the publication of its pivotal Phase 2b/3 (HERALD study) primary data of…
On Aug. 30, 2021, AXIMﾮ Biotechnologies announced that the Companyﾒs manufacturing partner Empowered Diagnostics had filed an amended…
On Aug. 27, 2021, the USDA’s National Veterinary Services Laboratories announced confirmation of SARS-CoV-2 (the virus that causes…
On Aug. 27, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Aug. 27, 2021, The National Institutes of Health announced that it had begun a clinical trial to…
On Aug. 26, 2021, the University of Nebraska Medical Center (UNMC) announced findings on airborne transmission have passed…
On Aug. 26, 2021, Pfizer and BioNTech announced the signing of a letter of intent with Eurofarma Laboratorios,…
On Aug. 25, 2021, Johnson & Johnson announced data supporting the use of its COVID-19 vaccine as a…
On Aug. 25, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Aug. 23, 2021, Dynavax Technologies and Biological E announced the execution of a commercial supply agreement of…
On Aug. 22, 2021, InBios announced that laboratory studies suggest its SCoV-2 Ag Detect Rapid Test detected the…
On Aug. 20, 2021, Regeneron announced that the United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency had…
On Aug. 18, 2021, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
On Aug. 18, 2021, the final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)…
On Aug. 18, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals,…
On Aug. 17, 2021, Our Future Health published a new tender for the processing, genotyping, and storage of…
On Aug. 16, 2021, CureVac and GSK announced publication on the preprint server bioRxiv of preclinical data investigating…
On Aug. 16, 2021, scientists at the National Institutes of Health (NIH) announced they had developed a new…
On Aug. 16, 2021, Pfizer and BioNTech announced that they had submitted Phase 1 data to the U.S….
On Aug. 16, 2021, ADMA Biologics announced that it had received U.S. Food and Drug Administration approval for…
On Aug. 14, 2021, the Ministry of Health of Cote d’Ivoire confirmed the country’s first case of Ebola…
On Aug. 13, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved TICOVACﾙ (tick-borne…
On Aug. 13, 2021, Rigel Pharma announced that the U.S. Food and Drug Administration (FDA) had informed the…
On Aug. 11, 2021, the National Institutes of Health (NIH) announced that one dose of a new monoclonal…
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
On Aug. 10, 2021, Cardinal Health announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19…